Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
  1. 4 Open-market sale See Remarks sold 3,026 shares at $20.40 ($61,715)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4/A Open-market sale Director sold 274,000 shares at $28.43 ($7,790,943)
  12. 4 Gift Director gave 172,840 shares (gift)
  13. 4 Open-market sale See Remarks sold 1,079 shares at $23.35 ($25,195)
  14. 4 Open-market sale CEO sold 9,790 shares at $23.35 ($228,597)
  15. 4 Open-market sale General Counsel sold 1,048 shares at $23.35 ($24,471)
  16. 4 Open-market sale See Remarks sold 4,046 shares at $23.35 ($94,474)
  17. 4 Open-market sale See Remarks sold 833 shares at $22.87 ($19,051)
  18. 4 Open-market sale Director sold 80,000 shares at an average $24.32 ($1,945,785)
  19. 4 Open-market sale See Remarks sold 12,532 shares at $24.64 ($308,763)
  20. 3 Insider Initial Statement of Ownership

Page 7 of 21 · 406 filings